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organisms (MDRO)Abstract Mucositis developing as a result of myelo-ablative high dose therapy administered prior
to hematopoietic stem cell transplantation (HSCT) is associated with the risk of bacteremia. The
aim of the present study was to detect the pattern of bacteremia coinciding with the present practice
of HSCT, to study the contribution of health-care associated infection (HAI) to the pattern of infec-
tion, in the context of the problem of antibiotic resistance in HSCT recipients.
Patients and methods: This is a retrospective, single center study including patients who developed
febrile neutropenia (FN) among HSCT recipients in one year duration.
Results: Ninety FN episodes were recorded in 50 patients. Out of 39 positive blood cultures, Gram
negative rods (GNR) were the predominant pathogens, constituting 67% (n= 26) of isolated
organisms, while 33% of infections were caused by gram positive cocci (GPC) (n= 13). Bacteremia
was signiﬁcantly associated with central venous line (CVL) infections and gastroenteritis (diarrhea
and vomiting) with a p-value 0.024, 0.20 and 0.0001, respectively. Multi-drug resistant organisms
(MDROs) were identiﬁed in 27 (69%) of the 39 positive blood cultures.
Conclusion: In one year duration, gram negative pathogens were the predominant causes of infec-
tion in HSCT recipients with high rates of MDROs in our institution. Gastroenteritis and central
venous line infections are the main sources of bacteremia.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.D license.Introduction
Despite the advances in conditioning, supportive care and pro-
phylaxis, infection remains a major cause of morbidity and
mortality in HSCT due to continued development of antimi-
crobial resistance and the emergence of new pathogens [1].
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ing the micro biome it was found that they may prevent colo-
nization of pathogenic microorganisms including MDROs.
This is achieved by many ways either competition of space
and resources or a complex immunologic and biochemical
interactions. The overuse and empirical introduction of anti-
bacterial agents may play a role in the appearance of MDROs.
The new approach now is to maintain an intact micro biome
through the usage of micro biome-sparing antimicrobial ther-
apy and discovering ways to augment host protective mecha-
nisms thus maintaining a healthy micro biota [2].
The most predominant type of bacterial infection when pa-
tients are neutropenic is bacteremia. The main sources of bac-
terial infection include central venous cathetes, oral ﬂora and
gut ﬂora via bacterial translocations [3]. Health-care associated
infections (HAI) present evolving challenges to the successful
management of infectious complications in this expanding pa-
tient population. Therefore, the aim of the present study was
primarily to detect the pattern of bacteremia in HSCT patients
coinciding with the present practice of HSCT, to study the
contribution of HAI to the pattern of infection, and, to inves-
tigate the problem of antibiotic resistance on the course and
outcome in transplant patients in our institution in one year
duration.
Patients and methods
This is a retrospective, single center study conducted at the
Microbiology laboratory of the clinical pathology department
in collaboration with the Bone Marrow Transplant unit, at
The National Cancer Institute of Cairo (NCI), Egypt, in one
year duration. During the period extending from the ﬁrst of
January till the end of December 2009, 80 patients had under-
gone HSCT for different hematological malignant disorders.
The study was approved by Ethics Committee of NCI and
an informed consent was obtained from all participants.
During this period, 90 bacteremic episodes were recorded in
50 patients only who showed neutropenia and fever. Their data
included were age, diagnosis, state of disease, clinically docu-
mented infection (CDI) especially central venous line (CVL)
and lower respiratory tract infections (LRTI), duration of epi-
sode, and broad spectrum antibiotics given with the need of
shift to second line. All patients were hospitalized during the
study period and if a patient developed fever >48 h after hos-
pitalization the case was considered febrile neutropenia.
Deﬁnitions
In the context of HSCT, fever was deﬁned as a single oral
temperature of 38.3 C, or a temperature more or equal to
38.0 C for 1 h at 2 times with a minimum interval of
12 h. Neutropenia described an absolute neutrophil count
(ANC) <0.5 · 109/L or <1.0 · 109/L, with decline predicted
over the next two days [4]. Lower respiratory tract infections
were deﬁned as any new inﬁltrate arising within 48 h before
or after the onset of fever and neutropenia.
Microbiology
Two blood culture sets were usually drawn from each patient
within the ﬁrst day of fever from two separate veins. If thecannula site, portacath, or central venous catheter (CVC)
was suspected as the source of infection, a blood sample was
obtained from it as well. Collected blood was directly injected
into Bactec (Becton Dickinsion, USA) culture vials and they
were incubated in the Bactec 9050 incubator. When the
blood culture revealed a potential contaminant, another posi-
tive blood culture, or other clinical evidence of ongoing blood
stream infections (BSI), such as rigors, hypotension, or docu-
mented infection at a second site with the same organism,
was required for conﬁrmation of true infection. Identiﬁcation
of isolates was carried out utilizing MicroScan dried gram
negative MIC/Combo and dried gram positive MIC/Combo
panels Siemens Healthcare Diagnostics Ltd. (Sir William Sie-
mens Sq. Frimley, Camberley, UK GU16 8QD) for gram-neg-
ative and gram positive organisms. The panel of antibiotics
used for gram negative included: amikacin, amoxicillin-clavul-
anate, ampicillin-sulbactam, cefepime, noroﬂoxacin, ceftazi-
dime, cefotaxime, ciproﬂoxacin, levoﬂoxacin, gentamicin,
tobramycin, imipenem and meropenem. For gram positives
the following panel was used amoxicillin-clavulanate, oxacillin,
cefepime, cefotaxime, ciproﬂoxacin, levoﬂoxacin, clindamycin,
imipenem, linezolid and vancomycin. Antimicrobial suscepti-
bility testing both manual using antibiotic disk on Muller Hin-
ton agar using petri dishes at 37 C for 24–48 h. [5], and
automated testing using minimal inhibitory concentration
(MIC) by the Microscan was determined by using the criteria
established by the National Committee for clinical laboratory
standards (CLSI) [6]. The multidrug resistant organism pheno-
type was deﬁned as diminished susceptibility toP3 antibiotics
of the antibiotic groups [7].
Management
According to NCI guidelines, empirical treatment was given to
F&N patients after withdrawal of blood samples for blood cul-
tures. The ﬁrst line of empirical regimen included a third gen-
eration cephalosporins and amikacin double agent
antimicrobial therapy for 3 days, antibiotics were continued
if the patient showed response. If fever persisted, treatment
was given according to microbiological results and/or clinical
examination necessitating shift or addition of antibiotics;
whereas if culture results were not indicative, a carbapenem
and antifungal were given. Both antibiotics were continued un-
til the patient became afebrile and ANC exceeded 0.5 · 109/L.
After recovery, the patients with persistent fever or clinical
symptoms related to the infectious episode were placed under
close follow up for 2 weeks for veriﬁcation.
Statistical methods
Data were analyzed using SPSSwin statistical package version
17. Chi-square test or Fisher’s Exact test was used to test the
relation between qualitative variables. A p-value less than
0.05 was considered signiﬁcant. All tests were two tailed.
Results
Patient characteristics
In the period from January ﬁrst to the end of December 2009,
blood stream infections were detected in 39 of 90 (43%) febrile
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tients’ age ranged from 3 to 62 years, with a mean age of
29 ± 15 years. There were 28 (56%) males and 22 (44%) were
females. The patients’ diagnoses were AML, ALL, NHL, and
other malignancies (CML, HD, MDS, and NB) in 24 (48%),
12 (24%), 7 (14%), and 7 (14%) patients; respectively.
Clinical features
Central venous line infection, diarrhea and LRTI were re-
corded in 16 (18%), 15 (17%) and 10 (11%) episodes;
respectively.
Microbiology
Out of 39 positive blood cultures, Gram negative rods (GNR)
were the predominant causative agents of BSI, constitutingTable 1 Isolated organisms from 39 bacteremic episodes in
stem cell transplant recipients with febrile neutropenia.
Organisms Number (%)
Gram positive organisms 13(33)
Coagulase negative staphylococci 09(23)
Streptococcus spp. 02(05)
Stapylococcus aureus, MRSA 02(05)
Gram negative organisms 26(67)
Non-fermenters 11
Acinetobacter sp. 05(13)
Pseudomonas sp. 05(13)
Stenotrophomonas maltophilia 01(02)
Enterobacteriaceae 15
E. coli 01(03)
Klebsiella spp. 03(08)
Enterobacter spp. 08(21)
Citrobacter spp. 02(05)
Serratia spp. 01(02)
Mixed gram positive and gram
negative (n= 3); included in GNR
MRSA=Methicillin resistant Staphylococcus aureus.
Table 2 Clinical characteristics of febrile neutropenic stem cell tr
episodes.
Factors Blood culture no
n= 51 N (%)
Central venous line infection, n= 16
No infection, n= 74 5 (9.8)
46 (90.2)
Lower respiratory tract infection, n= 10
No infection, n= 80 5 (9.8)
46 (90.2)
Diarrhea, n= 15
No diarrhea, n= 75
4 (7.8)
47 (92.2)
Vomiting, n= 8
No vomiting, n= 82
0 (0.0)
51 (100.0)
Duration of fever,<7
P7
35 (68.6)
16 (31.4)
Need of antibiotic shift, n= 26
No shift, n= 64 7 (13.7)
44 (86.3)67% (n= 26) of isolated organisms, while 33% of infections
were caused by gram positive cocci (GPC) (n= 13). Of the
GPC isolated, 90% were oxacillin resistant. Among the
GNR, Enterobacteriaceae were isolated from 15 cases (58%)
and, non-fermenters from 11 including the mixed samples
(42%). Bacterial growth was detected in 16 (17.8%) of CVL
blood samples, GNR were identiﬁed in 10 CVL infections
and GPC in 6. The organisms isolated from blood cultures
are summarized in Table 1. Table 2 demonstrates the different
clinical ﬁndings in relation to presence or absence of bactere-
mia. Multi-drug resistance was identiﬁed in 27 (69%) of the
39 positive blood cultures. Fig. 1 illustrates the results of anti-
biotic sensitivity of isolated organisms causing BSI.
Health-care associated infections
An outbreak was detected at the Bone Marrow Transplant
Unit (BMT) in NCI by the Microbiology laboratory staffansplant recipients in relation to results of blood culture in 90
growth Result bacterial growth
n= 39 N (%)
P-Value
11 (28.2)
28 (71.8)
0.024
5 (12.8)
34 (87.2)
0.741
11 (28.2)
28 (71.8)
0.020
8 (20.5)
31 (79.5)
0.001
21 (53.8)
18 (46.2)
0.152
19 (48.7)
20 (61.3)
<0.001
Fig. 1 Antibiotic sensitivity of Gram negative (GNR) and gram
positive organisms (GPC) isolated from positive blood cultures of
febrile neutropenicstem cell transplant recipients in one year
duration.
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ing the month of August; 2009. The outbreak constituted of 7
patients who were diagnosed during an episode of neutropenia
fever with E. cloacae isolated from their blood cultures. Inves-
tigations were carried out by the infection control team to de-
tect the cause of the outbreak and to prevent the spread of
infection. The cause of this outbreak was due to the presence
of new nurses at the BMT unit; who were not familiar with
the strict aseptic procedures, as they had not received appro-
priate training before working at BMT unit. These nurses were
dismissed from work at BMT. The 7 patients were properly
treated and came out alive. No further cases of E. cloacae
infection occurred afterward.
Course and outcome
The median duration of neutropenic fever episodes was 5 days.
The ﬁrst line of empirical antibiotic therapy (cefepime and
amikacin) was used in 43 of the 90 episodes; second line (carb-
apenem/amikacin) was given in 36 episodes, whereas mono-
therapy (cefepime or amikacin) was given in 11 episodes.
Antibiotic shift was required in 26 (28.9%) episodes, while
vancomycin was added in 30 (33.3%) episodes. Crude mortal-
ity was 10% (5/50), with 60% infection attributed mortality.
Discussion
Despite the advances in conditioning regimens, supportive care
and prophylaxis, infection remains a major cause of morbidity
and mortality in HSCT patients. In the present study, blood
stream infections were detected in 39 of 90 (43%) febrile neu-
tropenic episodes identiﬁed in 50 HSCT patients. Gram nega-
tive organisms were the predominant bacterial pathogens,
accounting for 67% of bacterial isolates. Similar results were
previously reported in HSCT recipients. In a retrospective
study investigating the impact of BSI on outcome of 246 allo-
geneic HSCT recipients between 1999 and 2006, GNR consti-
tuted 54% of the bacterial isolates [8]. In another study, it was
found that gram positive cocci accounted for 60% of bacterial
isolates as causes of BSI in allogeneic HSCT patients who re-
ceived levoﬂoxacin prophylaxis [9]. In the present study, GNR
isolates were signiﬁcantly associated with prolonged febrile
episodes and requirement of change of empirical line of ther-
apy. Antibiotic shift was needed in 26 episodes (29%), of
which 54% were for GNR pathogens. The shift was due to
the fact that the empirical guideline in BMT unit at NCI in-
cludes antibiotics which unfortunately does not cover extended
spectrum b-lactamase (ESBL) and a shift was needed whenever
an ESBL Gram negative organism was detected. Similarly, Liu
and his colleagues (2011) reported that HSCT patients with
GNR pathogens as causes of BSI had a signiﬁcantly increased
length of hospital stay (p= 0.014), and a signiﬁcantly greater
6-month mortality (p= 0.021) [8].
In the current study, the CVCs and GIT were the main por-
tals of entry of bacteria, especially GNR isolates. Central ve-
nous line infection, and diarrhea were coinciding with BSI in
16 (18%), and 15 (17%) episodes; respectively; and were signif-
icantly associated with GNR isolates. Health care associated
infections represent another important source of infection in
these vulnerable patients. In the current study, an outbreak
was recorded during the month of August, coinciding withthe new nurses in the unit who lacked the knowledge of proper
infection control measures necessary to prevent cross infection.
In our group of HSCT recipients, a high frequency of multi-
drug resistance was encountered in bacterial pathogens isolated
from blood cultures. Multi-drug resistance was identiﬁed in
69% (27/39) of bacteria isolated from positive blood cultures.
A high incidence of MDROs causing blood stream infections
was recently reported to be an increasing problem in critically
ill patients as a result of previous use of antibiotics and transfer
from other hospitals [10]. Escherichia coli resistance to quino-
lones has increased from 13% to 46% in a recent report from
a single cancer center, as a consequence of widespread use of
quinolones as prophylaxis for neutropenic patients; and 18%
of E. coli recovered from BSI were ESBL producing [11]. In pa-
tients receiving renal transplantation, infections caused by anti-
biotic resistant pathogens conferred a worse prognosis [12]. In
HSCT recipient’s previous intake of antibiotics was signiﬁ-
cantly associated with the development of antibiotic resistance
[8,9]. Levoﬂoxacin with penicillin or doxacycline prophylaxis
also contributes to the emergence of resistant GN infections
in allogeneic HSCT recipients over time [13].
The problem of antimicrobial resistance is highlighted by
The World Health Organization (WHO) and combating anti-
microbial resistance has been selected as the theme for World
Health Day 2011 [14]. The fear of carbapenemase producing
acquisition by GN pathogens is more aggravated in cancer pa-
tients especially HSCT recipients [15]. As the prevalence rates
of resistance in GN pathogens increases, the treatment options
available become limited. Thus, the WHO is calling all parties
involved in this problem to act and take responsibility for com-
bating antimicrobial resistance [14].
In agreement with our ﬁndings it is stated that in National
Comprehensive Cancer Network (NCCN) that vascular access
infections are common as a consequence of the utility of vas-
cular associated device in patients undergoing intensive or cyc-
lic chemotherapy [16]. The gut plays a prominent role in the
development of resistant micro-organisms in the community,
long term care facilities and hospitals [17]. The emergence of
MDROs in the gut maybe related to the ingestion of highly
pathogenic microorganism or to antibiotic induced alterations
of the gut micro biome [2]. This was aided by the ﬁnding that
bacteremia was signiﬁcantly associated with GIT infections in
our patients.
Thus, we conclude that Gram negative pathogens are the
predominant organisms isolated from blood cultures of trans-
planted patients at our institute. Although coagulase negative
Staphylococci are considered normal ﬂora, but in the presence
of a central line and infection with gram negative organisms in
association of febrile neutropenia, we consider these patients
to be suffering from mixed infections. Endogenous bacteria
through GIT constitute an important source of infection in
HSCT recipients. Gastroenteritis and central venous line infec-
tions are the main sources of bacteremia. Health care acquired
infections constitute an important source of infection in BMT
unit at NCI. Due to the presence of newly appointed nurses in
the wards a major outbreak was recorded during this period
and attributed in its major part to their lack of proper hygiene
and the adequate use of safety measures to prevent the spread
of infections. Thus, extreme measures should be taken in order
to prevent the occurrence of outbreaks through careful moni-
toring and continuous education of healthcare workers.
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patients at our institute are alarming and necessitate every ef-
fort to control this problem. As health care acquired infections
caused by multi-drug resistant organisms complicate therapy
and limit treatment options, efforts should be directed toward
continuous monitoring to ensure strict adherence to infection
control measures and proper use of antibiotics to minimize
the incidence of the aggravating problem of MDROs.Conﬂict of interest
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